<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02607878</url>
  </required_header>
  <id_info>
    <org_study_id>432/14</org_study_id>
    <nct_id>NCT02607878</nct_id>
  </id_info>
  <brief_title>Automated Pupillometry for Coma Prognostication After Cardiac Arrest</brief_title>
  <official_title>Automated Pupillometry for Coma Prognostication After Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera San Gerardo di Monza</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lund University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cochin University Hospital, Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier du Luxembourg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Sedation and therapeutic hypothermia (TH) delay neurological responses and might&#xD;
      reduce the accuracy of clinical examination to predict outcome after cardiac arrest (CA).&#xD;
      Electroencephalography (EEG) and somato-sensory evoked potentials (SSEP) might significantly&#xD;
      improve prognostication of post-CA coma, however, EEG and SSEP are not always available and&#xD;
      require specific expertise for their interpretation. Automated video pupillometry is a novel&#xD;
      electronic device that contains an infrared light camera which enables to measure&#xD;
      quantitatively the percentage of pupillary reaction to a calibrated light stimulation. In a&#xD;
      recent study of a cohort of comatose CA survivors (n=50 patients) it was found that&#xD;
      quantitative PLR was more accurate than standard PLR (manual pen light) in predicting 3-month&#xD;
      outcome, irrespective of temperature and sedation, and had comparable prognostic accuracy&#xD;
      than electrophysiological exams, including electroencephalography (EEG) and somato-sensory&#xD;
      evoked potentials (SSEP).&#xD;
&#xD;
      Aim of the study: In light of these promising results, the investigators would like to&#xD;
      confirm the prognostic value of quantitative PLR in a large multicenter cohort of comatose&#xD;
      post-CA patients.&#xD;
&#xD;
      Design of the study: Prospective, multicenter, observational outcome trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study: Prospective, multicenter study. The study will be double-blinded, i.e. the&#xD;
      clinician/nurse performing the tests will not be involved in patient care and clinicians in&#xD;
      charge of patients will not be aware of automated pupillometry data. Patient care will not be&#xD;
      influenced by pupillometry.&#xD;
&#xD;
      Patient population:&#xD;
&#xD;
      The investigators plan to include 500 comatose post-CA patients. The centers have been&#xD;
      selected based on their expertise and publication track record on the topic, and because they&#xD;
      are actively involved in the Neurointensive Care section (NIC) of the European Society of&#xD;
      Intensive Care Medicine (ESICM). The study will take place at the Department of Intensive&#xD;
      Care of the participating centers.&#xD;
&#xD;
      Patients will be managed according to standards of post-resuscitation care and based on local&#xD;
      algorithms for the treatment of post-CA coma.&#xD;
&#xD;
      Quantitative pupillary light reactivity (PLR, using the NeurOptics NPi-200 pupillometer) will&#xD;
      be performed on ICU admission and then every 12 hours up to 72 hours after CA. At each time&#xD;
      point, one measurement will be assessed on both eyes.&#xD;
&#xD;
      The primary variables for analysis will be the neurological pupil index (NPi) and the pupil&#xD;
      size for both eyes. Standard PLR using a manual pen light will be performed simultaneously at&#xD;
      each time point, as part of standard care.&#xD;
&#xD;
      EEG, SSEP and sampling for serum neuron specific enolase (NSE) will be performed at 24h and&#xD;
      at 48-72h, according to local practices and as part of standard care.&#xD;
&#xD;
      The predictive value of NPi will be analyzed using the area under the receiving operator&#xD;
      characteristics (ROC) curve, and compared to that of standard PLR, EEG, SSEP and NSE:&#xD;
      sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV),&#xD;
      unweighted accuracy, with 95% binomial confidence intervals, will be calculated. Associations&#xD;
      with outcome will adjusted for main baseline demographics (age, initial CA arrest rhythm,&#xD;
      time from CA to tROSC), dose of sedation-analgesia and vaso-active agents, and the SOFA&#xD;
      score, using a logistic regression model.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Neurological outcome</measure>
    <time_frame>3-6 months</time_frame>
    <description>Neurological outcome is assessed by a semi-structured telephone interview with the patient or the patient's relatives using the Glasgow-Pittsburgh Cerebral Performance Categories (CPC). The CPC result is then categorized as favorable outcome (CPC 1-2, including good recovery and moderate disability), vs. unfavorable outcome (CPC 3-5, including severe disability, vegetative state and death).</description>
  </primary_outcome>
  <enrollment type="Actual">470</enrollment>
  <condition>Cardiac Arrest</condition>
  <condition>Comatose</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with coma after cardiac arrest (CA)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients with coma after cardiac arrest (CA)&#xD;
&#xD;
          -  Glasgow Coma Scale (at inclusion): ≤ 6&#xD;
&#xD;
          -  Patients with CA due to ventricular fibrillation (VF) and non-VF (including asystole&#xD;
             and pulseless electrical activity) rhythms&#xD;
&#xD;
          -  Cardiac and non-cardiac causes of CA will be included&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
&#xD;
          -  Unable to obtain consent&#xD;
&#xD;
          -  Follow-up unavailable&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauro Oddo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHUV, Lausanne University Hospital, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Erasme University Hospital</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital, Grenoble</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cochin Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite University, Berlin, Germany</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera San Gerardo di Monza</name>
      <address>
        <city>Monza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catholic University of the Sacred Heart</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du Luxembourg</name>
      <address>
        <city>Luxembourg</city>
        <country>Luxembourg</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lund University Hospital</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHUV, Lausanne University Hospital</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Luxembourg</country>
    <country>Netherlands</country>
    <country>Sweden</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 2, 2015</study_first_submitted>
  <study_first_submitted_qc>November 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2015</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Mauro ODDO</investigator_full_name>
    <investigator_title>Médecin adjoint, PD-MER I</investigator_title>
  </responsible_party>
  <keyword>Cardiac arrest</keyword>
  <keyword>Coma</keyword>
  <keyword>Prognosis</keyword>
  <keyword>Automated pupillometry</keyword>
  <keyword>EEG</keyword>
  <keyword>Evoked potentials</keyword>
  <keyword>Targeted Temperature Management (TTM)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

